Cours Amarillo Biosciences, Inc. Other OTC
Actions
AMAR
US02301P2056
Recherche biotechnologique et médicale
CA 2022 | 3,52 M 3,2 M | CA 2023 | 122 k 111 k | Capitalisation | 8,32 M 7,56 M |
---|---|---|---|---|---|
Résultat net 2022 | -14 M -12,72 M | Résultat net 2023 | -13 M -11,81 M | VE / CA 2022 | 3,36 x |
Trésorerie nette 2022 | 585 k 531 k | Dette nette 2023 | 3,81 M 3,46 M | VE / CA 2023 | 99,3 x |
PER 2022 |
-0,6
x | PER 2023 |
-0,61
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 46,51% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 15/04/21 |
Lawrence Lin
COO | Chief Operating Officer | 55 | 01/08/21 |
Shu Ying Pan
SAM | Sales & Marketing | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Yao Chung Chiang
BRD | Director/Board Member | 70 | 15/04/21 |
Pao Sheng Wei
BRD | Director/Board Member | 66 | 15/06/22 |
Chung Yi Tsai
BRD | Director/Board Member | 47 | 15/04/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+9,42% | 114 Md | |
+11,84% | 104 Md | |
-14,15% | 22,41 Md | |
-1,05% | 22,28 Md | |
-5,29% | 19,07 Md | |
-38,29% | 18 Md | |
-4,16% | 17,89 Md | |
+7,99% | 14,28 Md | |
+36,24% | 12,55 Md |